Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > From Linkedin

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Jul 22, 2024 7:49pm

65 Views

Post# 36143530

RE:RE:RE:RE:RE:RE:RE:RE:From Linkedin

Both sides lie and should both be held accountable when the law has been broken. I continue to say this and you continue to ignore it.

Your savior is no savior. I'm asking you again to look in to this stuff and educate yourself. Look in to his Epshtein ties. Look in to Fink and Dimon. Look in to Thiel. Didnt he give Fauci a presidential commendation. He's surrounding himself with all the people you "Republicans" say are the deep state and that doesn't concern you?

<< Previous

Bullboard Posts

Next >>

The long-term forecast for lithium stocks in 2024